drugset / Trial / NCT04919135

Mesenchymal Stem/Stromal Cell Therapy in the Treatment of Frailty

NCT04919135

RandomizedParallel-groupSingle-blindTreatment

Summary

This trial is to investigate the safety and potential therapeutic efficacy of allogeneic administration of umbilical cord-derived MSCs (UC-MSCs) in combination with standard frailty treatment in Vietnam

Timeline

Start
2021-10-19
Primary completion
2023-04-20
Completion
2024-12-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject mesenchymal stem cells Cell therapy 1.5e+06 cells/kg Intravenous
Background Bioflex Unknown
Background Hightamine Unknown
Background Total calcium Unknown

Indications

No indication recorded.